3-hydroxyisobutyric acid has been researched along with Liver Cirrhosis in 1 studies
3-hydroxyisobutyric acid: RN given refers to cpd without isomeric designation
3-hydroxyisobutyric acid : A 4-carbon, branched hydroxy fatty acid and intermediate in the metabolism of valine.
Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biliotti, E | 1 |
| Giampaoli, O | 1 |
| Sciubba, F | 1 |
| Marini, F | 1 |
| Tomassini, A | 1 |
| Palazzo, D | 1 |
| Capuani, G | 1 |
| Esvan, R | 1 |
| Spaziante, M | 1 |
| Taliani, G | 1 |
| Miccheli, A | 1 |
1 other study available for 3-hydroxyisobutyric acid and Liver Cirrhosis
| Article | Year |
|---|---|
Urinary metabolomics of HCV patients with severe liver fibrosis before and during the sustained virologic response achieved by direct acting antiviral treatment.
Topics: Aged; Antiviral Agents; Biomarkers; Hepatitis C; Humans; Hydroxybutyrates; Liver Cirrhosis; Male; Me | 2021 |